Physician profile

William I Crevier

Internal Medicine · Orland Park, IL

NPI 1477509347

$10,025.42

in general payments reported to CMS, 2019-2025

46 companies · $970 in 2025

The $970 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,417.49

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $3,233.48 2019-2025 Farxiga, Breztri, Airsupra
Glaxosmithkline, LLC. $1,067.58 2019-2025 Trelegy Ellipta, Arexvy, Shingrix
Pfizer INC. $816.08 2019-2023
Lilly USA, LLC $773.08 2019-2025 Mounjaro, Zepbound, Trulicity
Janssen Pharmaceuticals, INC $753.10 2019-2022
Boehringer Ingelheim Pharmaceuticals, INC. $622.77 2019-2023 Jardiance
Novo Nordisk INC $439.51 2019-2025 Rybelsus, Ozempic
Bayer Healthcare Pharmaceuticals INC. $255.72 2021-2023
Exact Sciences Corporation $180.97 2023-2025 Cologuard Collection Kit, The Cologuard Plus Collection Kit
Watermark Medical, INC. $160.31 2022
Abbvie INC. $159.35 2021-2025
Mylan Specialty L.P. $145.93 2020-2023 Yupelri
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $104.06 2020-2022
Almatica Pharma LLC $87.06 2021-2022
Boston Scientific Corporation $82.11 2019-2020
Show all 46 companies
CompanyGeneral paymentsYearsTop products
Tactile Systems Technology INC $81.68 2019
Philips North America LLC $80.20 2020-2022
Ibsa Pharma INC. $79.48 2019-2025 Tirosint, Licart, Flector
Corcept Therapeutics $74.80 2025 Korlym
Bausch Health US, LLC $73.24 2020-2025 Aplenzin, Wellbutrin
Inspire Medical Systems, INC. $67.20 2023-2024 Inspire
Horizon Therapeutics Plc $53.72 2021-2022
Idorsia Pharmaceuticals US INC $53.32 2022-2023 Quviviq
Biogen, INC. $53.15 2021-2022
Amarin Pharma, INC. $53.07 2019-2020
Vivus LLC $50.20 2024-2025 Pancreaze
Merck Sharp & Dohme LLC $48.41 2019-2020
E.R. Squibb & Sons, L.L.C. $38.51 2021-2022
Redhill Biopharma INC. $33.97 2020
Medtronic, INC. $33.85 2021
Teva Pharmaceuticals USA, INC. $30.02 2022-2023 Airduo Digihaler
Medicure Pharma INC. $29.90 2021-2022
Allergan, INC. $25.73 2019
Insmed, INC. $20.00 2019
Hikma Pharmaceuticals USA $17.04 2020
Sun Pharmaceutical Industries INC. $16.45 2022
Avion Pharmaceuticals $15.66 2023 NP Thyroid 60
Sobi, INC $15.05 2019
Azurity Pharmaceuticals, INC. $13.75 2023 Adthyza
Lucid Diagnostics INC. $13.10 2023
Nestle Healthcare Nutrition INC. $12.62 2022
Echosens North America, INC. $12.39 2025 Fibroscan
Vistapharm, INC. $12.23 2021
Nalpropion Pharmaceuticals LLC $12.19 2019
Biodelivery Sciences International, INC. $11.87 2021
Astellas Pharma US INC $11.51 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

William I Crevier

$10,025.42

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $970 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/339521/william-i-crevier

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.